Text size Large-cap biotech will offer a smoother ride than small, and Vertex, in particular, looks attractive. Igor Akimov/Dreamstime.com Biotech stocks began the year in much the same way they ended...
Tag: Trusts/Funds/Financial Vehicles
Unprofitable tech trades are off to an ugly 2022. Here are the ETFs to consider as Cathie Wood’s Ark sinks.
Happy Thursday! In mythology, Janus is a god of transitions who is often depicted as a two-faced deity. A mere three sessions into the month of January, and some investors already may be feeling whipl...
Alibaba’s ‘long-term strategy is intact,’ analyst says as stock rises
U.S.-listed shares of Alibaba Group Holding Ltd. have come under pressure in recent months amid concerns about U.S.-China tensions and a slowdown in the company’s key business, but one analyst says th...
This investing legend has been predicting surprises for the last 37 years. Here’s how he did last year — and what he’s predicting now
Byron Wien, the vice chairman of private-equity giant Blackstone, has been making his list of ten surprises for 37 years. Previously the chief U.S. investment strategist at Morgan Stanley, Wien has be...
Stitch Fix Stock Has Cratered. One Investor’s $100 Million Bet on a Comeback.
Text size Courtesy of Stitch Fix Stitch Fix stock has tumbled in 2021, but one of the largest investors in the online apparel retailer has been racking up big stock buys. Stitch Fix (ticker: SFIX) sto...
20 cheap value stocks that Wall Street expects to rise up to 58%
There are plenty of arguments for why the bull market for U.S. stocks will continue in 2022. But investors’ focus appears to have shifted recently in favor of value stocks, rather than the growth stoc...